Table 3.
Associations Between Severity of DR and Muscle Cramps in Type 2 Diabetes
| Variable | Model 1 | Model 2 | Model 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | p value | p value for Trend | OR (95% CI) | p value | p value for Trend | OR (95% CI) | p value | p value for Trend | |
| Patients without DR | 1 [Reference] | p<0.05 | 1 [Reference] | p<0.05 | 1 [Reference] | p<0.05 | |||
| Patients with NPDR | 1.73 (0.85–3.51) | 0.13 | 1.83 (0.89–3.78) | 0.104 | 1.76 (0.79–3.01) | 0.164 | |||
| Patients with PDR | 9.04 (2.42–33.8) | 0.01 | 11.8 (2.41–58.1) | 0.02 | 8.02 (1.41–45.4) | 0.019 |
Notes: Model 1 was adjusted for age. Model 2 includes all variables in model 1 plus HbA1c and duration of diabetes (variables associated with diabetic retinopathy), Model 3 includes all variables in model 2 plus albumin, vitamin D, calcium, and magnesium.